Walleye Trading LLC Beam Therapeutics Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $155,190 - $190,495	5,293 Added 633.13%	6,129 $195,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $366,744 - $593,481	-12,164 Reduced 93.57%	836 $25,000
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $477,489 - $670,800	13,000 New	13,000 $508,000
Q2 2022 Aug 08, 2022	BUY	$29.86 - $62.36 $32,666 - $68,221	1,094 New	1,094 $42,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.74B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.